Detalhe da pesquisa
1.
Incidence of Anicteric Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome and Outcomes with Defibrotide following Hematopoietic Cell Transplantation in Adult and Pediatric Patients.
Biol Blood Marrow Transplant
; 26(7): 1342-1349, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32200121
2.
Pooled analysis of Day 100 survival for defibrotide-treated patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome and ventilator or dialysis dependence following haematopoietic cell transplantation.
Br J Haematol
; 190(4): 583-587, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32157682
3.
Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome.
Br J Haematol
; 181(6): 816-827, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29767845
4.
Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome following nontransplant-associated chemotherapy: Final results from a post hoc analysis of data from an expanded-access program.
Pediatr Blood Cancer
; 65(10): e27269, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29873895
5.
A Meta-Analysis Evaluating the Incidence of Bleeding Events With Intravenous Defibrotide Treatment Outside the Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Setting.
Clin Appl Thromb Hemost
; 26: 1076029620935202, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32687402